Dr. Jiasen Wang, MD

Dr. Wang practices at Pacific Coast Plastic Surgery Center, Inc in Santa Monica, California.

Dr. Wang's NPI, 1760045355, was assigned on April 18, 2019. Dr. Wang graduated from McGovern Medical School in 2019. Dr. Wang holds New Mexico license MD2023-1076.

Dr. Wang's primary practice is Pacific Coast Plastic Surgery Center, Inc, at 1301 20th St, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 453-2733.

Dr. Wang's primary practice is Pacific Coast Plastic Surgery Center, Inc in Santa Monica, California. The medical group on file is Bennett Surgery Center. Dmand AI also links Dr. Wang to 3 more group practices and clinics, 3 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wang is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Wang's licenses on file in 4 states: New Mexico, California, Illinois and Missouri.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, corns and calluses, itchy rashes and scalp rash among the conditions Dr. Wang treats.

CMS data shows 1,402 Medicare services from Dr. Wang across 15 procedure codes in 2024, for 346 Medicare patients. Medicare paid $74,679 for them. Every service was in an office.

CMS counts 346 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 142 patients. 73% of them have high cholesterol, and 62% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 71, with 44% women.

In 2024, Dr. Wang wrote 303 Medicare Part D claims for 149 patients. 92% of them were for generic drugs. CMS names the drug for 213 of them, across 8 drugs with 11 or more claims each, at $49,757 in total drug cost. In 2023, CMS named 257 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 277 procedures of melanoma (skin cancer) excision by Dr. Wang, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Wang, published from 2017 to 2025. 2017 was the busiest year, with 2. The most frequent topics are Checklist and Guideline Adherence. Dr. Wang has published most often in JAAD Case Rep. Dr. Wang's most frequent co-authors are Jocelyn Elizabeth Abraham, Kevin P. Lally, MD and Kathryn Tinsley Anderson, MD, MPH, MS.

CMS Open Payments shows 46 general payments to Dr. Wang from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $718.

Dr. Wang graduated from McGovern Medical School in 2019.

Dr. Wang is in network with 7 carriers, including Aetna, Elevance and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.